Conformational restriction shapes the inhibition of a multidrug efflux adaptor protein

Nat Commun. 2023 Jul 18;14(1):3900. doi: 10.1038/s41467-023-39615-x.

Abstract

Membrane efflux pumps play a major role in bacterial multidrug resistance. The tripartite multidrug efflux pump system from Escherichia coli, AcrAB-TolC, is a target for inhibition to lessen resistance development and restore antibiotic efficacy, with homologs in other ESKAPE pathogens. Here, we rationalize a mechanism of inhibition against the periplasmic adaptor protein, AcrA, using a combination of hydrogen/deuterium exchange mass spectrometry, cellular efflux assays, and molecular dynamics simulations. We define the structural dynamics of AcrA and find that an inhibitor can inflict long-range stabilisation across all four of its domains, whereas an interacting efflux substrate has minimal effect. Our results support a model where an inhibitor forms a molecular wedge within a cleft between the lipoyl and αβ barrel domains of AcrA, diminishing its conformational transmission of drug-evoked signals from AcrB to TolC. This work provides molecular insights into multidrug adaptor protein function which could be valuable for developing antimicrobial therapeutics.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / pharmacology
  • Bacterial Outer Membrane Proteins / metabolism
  • Biological Transport
  • Escherichia coli / metabolism
  • Escherichia coli Proteins* / metabolism
  • Membrane Transport Proteins* / metabolism
  • Multidrug Resistance-Associated Proteins / metabolism

Substances

  • Membrane Transport Proteins
  • Escherichia coli Proteins
  • Multidrug Resistance-Associated Proteins
  • Anti-Bacterial Agents
  • Bacterial Outer Membrane Proteins
  • AcrB protein, E coli